Latest Updates of Key Players in the U.S. Drug Testing Market

Recent Developments in the U.S. Drug Testing Market
- In April 2026, Labcorp, a global provider of laboratory testing services, introduced the Labcorp Fentanyl Urine Visual Test, the first FDA-cleared rapid fentanyl test manufactured in the U.S.. Designed to support healthcare professionals in emergency departments, hospitals, and clinics, the test provides results within 10 minutes, enabling faster identification of suspected fentanyl exposure and helping clinicians make timely treatment decisions when rapid intervention is critical.
- In January 2025, the Substance Abuse and Mental Health Services Administration and the Department of Health and Human Services published an issuance of authorized drug testing panels in the Federal Register. The guidance adds fentanyl to the panels of Schedule I and II drugs and biomarkers authorized for testing in federal workplace drug testing programs.
Market Ecosystem Analysis
| Ecosystem Segment | Key Participants | Role in Market |
| Technology Providers | Abbott, Thermo Fisher Scientific, Bio-Rad Laboratories, Dräger | Develop analytical instruments, immunoassays, toxicology platforms, breath testing systems |
| Product Manufacturers | Abbott, OraSure Technologies, Premier Biotech, Alfa Scientific Designs | Manufacture rapid drug screening kits, oral-fluid collection devices, testing consumables |
| Drug Testing Laboratories | Quest Diagnostics, Labcorp, Clinical Reference Laboratory (CRL), Millennium Health | Conduct high-volume laboratory testing and confirmatory toxicology services |
| Service Providers | DISA Global Solutions, First Advantage, HireRight, Cordant Health Solutions | Workplace testing administration, compliance management, occupational health services |
| Platform Providers | First Advantage, HireRight, DISA Global Solutions | Drug testing workflow, reporting, compliance, employer screening platforms |
| CROs / Specialized Testing Providers | Cordant Health Solutions, Millennium Health | Toxicology and monitoring programs supporting healthcare and government customers |
| Software Vendors | First Advantage, HireRight, DISA Global Solutions | Digital reporting, chain-of-custody tracking, compliance management systems |
| Research Institutions | SAMHSA-certified laboratories, university toxicology centers, NIDA-supported programs | Method validation, toxicology research, testing standards development |
| End-User Industries | Transportation, Healthcare, Manufacturing, Construction, Energy, Government, Logistics | Major purchasers of testing services and products |
Supply Chain Analysis
R&D:
- Research and development services in the U.S. drug testing market include discovery, preclinical research, clinical trials, regulatory review, and post-market monitoring.
- Key Players: Thermo Fisher Scientific and OraSure Technologies
Manufacturing Processes:
- Manufacturing processes include raw material testing and procurement, in-process controls (IPC), end product release testing, and stability testing.
- Key Players: Clinical Reference Laboratory and Abbott Laboratories
Patient Services:
- Major services of U.S. drug testing involve the full spectrum of care patients receive during the screening process, from sample collection to output interpretation.
- Key Players: Quest Diagnostics and Labcorp
| Tier 1 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Quest Diagnostics | Secaucus, New Jersey | United States | Largest U.S. drug testing laboratory network; dominant workplace testing provider | Workplace drug testing, toxicology testing, laboratory services |
| Labcorp | Burlington, North Carolina | United States | Extensive toxicology and workplace testing operations nationwide | Drug screening, toxicology services, employer testing programs |
| Abbott | Abbott Park, Illinois | United States | Leading supplier of rapid and laboratory drug screening technologies | Toxicology analyzers, rapid drug tests, immunoassays |
| Thermo Fisher Scientific | Waltham, Massachusetts | United States | Major provider of LC-MS/MS and confirmatory toxicology platforms | Toxicology analyzers, chromatography systems, reagents |
| OraSure Technologies | Bethlehem, Pennsylvania | United States | Market leader in oral-fluid drug testing solutions | Oral-fluid collection devices, toxicology testing products |
| Tier 2 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| First Advantage | Atlanta, Georgia | United States | Major workplace screening and compliance provider | Drug testing administration, workforce screening |
| DISA Global Solutions | Houston, Texas | United States | Large occupational health and workplace testing network | Drug testing management, compliance solutions |
| Clinical Reference Laboratory | Lenexa, Kansas | United States | Significant toxicology and employer testing provider | Laboratory drug testing, toxicology services |
| Cordant Health Solutions | Denver, Colorado | United States | Specialized toxicology and medication monitoring provider | Drug monitoring, toxicology analytics |
| Dräger | Lübeck | Germany | Strong position in alcohol and drug detection technologies | Breath alcohol testing, roadside screening systems |
| Tier 3 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Psychemedics Corporation | Acton, Massachusetts | United States | Leading hair follicle testing specialist | Hair drug testing services |
| Omega Laboratories | Mogadore, Ohio | United States | Specialized hair and oral-fluid testing laboratory | Hair testing, toxicology services |
| Premier Biotech | Minneapolis, Minnesota | United States | Rapidly expanding oral-fluid testing supplier | Drug screening kits, oral-fluid testing |
| Bio-Rad Laboratories | Hercules, California | United States | Provides toxicology and analytical testing technologies | Diagnostic reagents, toxicology solutions |
| HireRight | Nashville, Tennessee | United States | Growing presence in workplace drug screening programs | Drug testing administration, employment screening |
Market Growth
The U.S. drug testing market size was valued at US$ 2.62 billion in 2025 and is projected to grow to 2.77 billion in 2026. Forecasts suggest it will reach approximately US$ 4.65 billion by 2035, registering a CAGR of 5.9% during the period.

Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking